Copan Diagnostics, Inc., Carlsbad, California, USA.
J Clin Microbiol. 2024 Oct 16;62(10):e0088024. doi: 10.1128/jcm.00880-24. Epub 2024 Sep 10.
A recent article by Rodino et al. published in the (K. G. Rodino, P. M. Luethy, A. N. Abbott, J. M. Bender, A. R. Eberly, M. Gitman, A. Leber, and J. Dien Bard, J Clin Microbiol 62:e00359-24, 2024, https://doi.org/10.1128/jcm.00359-24) hones in on clinical consultation as a way for clinical microbiology laboratory directors (CMLDs) to provide evidence of our worth. They relate that, unlike our physician colleagues, we are unable to generate billing for clinical consultations, relative value units, or other metrics that could assist to describe our import. Their study evaluated consultations performed by CMLDs as a way to underscore our importance as a key member of the healthcare team.
最近,罗迪诺等人在《临床微生物学杂志》(K. G. Rodino、P. M. Luethy、A. N. Abbott、J. M. Bender、A. R. Eberly、M. Gitman、A. Leber 和 J. Dien Bard,J Clin Microbiol 62:e00359-24,2024,https://doi.org/10.1128/jcm.00359-24)上发表的一篇文章,着重探讨了临床咨询作为临床微生物学实验室主任(CMLD)提供自身价值的一种方式。他们指出,与我们的医生同事不同,我们无法为临床咨询、相对价值单位或其他可以帮助描述我们重要性的指标开具账单。他们的研究评估了 CMLD 进行的咨询,以强调我们作为医疗保健团队关键成员的重要性。